Home>SLAMF3 promotes Th17 differentiation and is reversed by iguratimod through JAK1/STAT3 pathway in primary Sjögren’s syndrome
SLAMF3 promotes Th17 differentiation and is reversed by iguratimod through JAK1/STAT3 pathway in primary Sjögren’s syndrome
- Impact factors: 5.6
- Publication: INTERNATIONAL IMMUNOPHARMACOLOGY
- Author:Peini Hu, Juan Cai, Chunshu Yang, Lingling Xu, Siyang Ma, Haining Song, Pingting Yang
- DOI citation-doi:10.1016/j.intimp.2023.111282
- Date:2023-12-06T00:00:00.000Z